Cancer Research Campaign health education programme to promote the early detection of cutaneous malignant melanoma. II. Characteristics and incidence of melanoma. 1995

J Melia, and E J Cooper, and T Frost, and R Graham-Brown, and J Hunter, and A Marsden, and A Du Vivier, and J White, and S Whitehead, and A P Warin
Cancer Screening Evaluation Unit, Institute of Cancer Research, Sutton, Surrey, UK.

The effect on the detection and characteristics of melanoma, resulting from the Cancer Research Campaign's health education programme to promote the early detection of melanoma in the general population, was studied from 1987 to 1989. The seven study areas in England and Scotland yield a target population of 3.6 million. Data were collected from local clinic-based registers, pathology laboratories, and the cancer registries. The average annual incidence rates of melanoma were seven and 12 per 10(5) in males and females, respectively, age-standardized to England and Wales, 1988. These rates are similar to the national figures for Scotland, where there is a national melanoma register, but higher than those reported by the English and Welsh cancer registries. The incidence was significantly higher in females than males (P < 0.001), and increased with age. Fifty-three per cent and 65% of cases in males and females, respectively, were thin (Breslow thickness < or = 1.5 mm), similar to the national figures from Scotland. No significant decrease in the incidence of late-stage tumours was found in either sex as a result of the campaign. Because of difficulties with ascertainment of cases in England, the main evaluation will focus on future trends in mortality rates for melanoma.

UI MeSH Term Description Entries
D008297 Male Males
D008545 Melanoma A malignant neoplasm derived from cells that are capable of forming melanin, which may occur in the skin of any part of the body, in the eye, or, rarely, in the mucous membranes of the genitalia, anus, oral cavity, or other sites. It occurs mostly in adults and may originate de novo or from a pigmented nevus or malignant lentigo. Melanomas frequently metastasize widely, and the regional lymph nodes, liver, lungs, and brain are likely to be involved. The incidence of malignant skin melanomas is rising rapidly in all parts of the world. (Stedman, 25th ed; from Rook et al., Textbook of Dermatology, 4th ed, p2445) Malignant Melanoma,Malignant Melanomas,Melanoma, Malignant,Melanomas,Melanomas, Malignant
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009367 Neoplasm Staging Methods which attempt to express in replicable terms the extent of the neoplasm in the patient. Cancer Staging,Staging, Neoplasm,Tumor Staging,TNM Classification,TNM Staging,TNM Staging System,Classification, TNM,Classifications, TNM,Staging System, TNM,Staging Systems, TNM,Staging, Cancer,Staging, TNM,Staging, Tumor,System, TNM Staging,Systems, TNM Staging,TNM Classifications,TNM Staging Systems
D004739 England A part of Great Britain within the United Kingdom.
D005260 Female Females
D006266 Health Education Education that increases the awareness and favorably influences the attitudes and knowledge relating to the improvement of health on a personal or community basis. Community Health Education,Education, Health,Education, Community Health,Health Education, Community
D006293 Health Promotion Encouraging consumer behaviors most likely to optimize health potentials (physical and psychosocial) through health information, preventive programs, and access to medical care. Health Campaigns,Promotion of Health,Wellness Programs,Promotional Items,Campaign, Health,Campaigns, Health,Health Campaign,Health Promotions,Item, Promotional,Items, Promotional,Program, Wellness,Programs, Wellness,Promotion, Health,Promotional Item,Promotions, Health,Wellness Program
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

J Melia, and E J Cooper, and T Frost, and R Graham-Brown, and J Hunter, and A Marsden, and A Du Vivier, and J White, and S Whitehead, and A P Warin
October 1988, BMJ (Clinical research ed.),
J Melia, and E J Cooper, and T Frost, and R Graham-Brown, and J Hunter, and A Marsden, and A Du Vivier, and J White, and S Whitehead, and A P Warin
September 1988, BMJ (Clinical research ed.),
J Melia, and E J Cooper, and T Frost, and R Graham-Brown, and J Hunter, and A Marsden, and A Du Vivier, and J White, and S Whitehead, and A P Warin
August 1988, BMJ (Clinical research ed.),
J Melia, and E J Cooper, and T Frost, and R Graham-Brown, and J Hunter, and A Marsden, and A Du Vivier, and J White, and S Whitehead, and A P Warin
March 1987, Harefuah,
J Melia, and E J Cooper, and T Frost, and R Graham-Brown, and J Hunter, and A Marsden, and A Du Vivier, and J White, and S Whitehead, and A P Warin
September 2001, British journal of cancer,
J Melia, and E J Cooper, and T Frost, and R Graham-Brown, and J Hunter, and A Marsden, and A Du Vivier, and J White, and S Whitehead, and A P Warin
April 1992, BMJ (Clinical research ed.),
J Melia, and E J Cooper, and T Frost, and R Graham-Brown, and J Hunter, and A Marsden, and A Du Vivier, and J White, and S Whitehead, and A P Warin
November 1993, European journal of epidemiology,
J Melia, and E J Cooper, and T Frost, and R Graham-Brown, and J Hunter, and A Marsden, and A Du Vivier, and J White, and S Whitehead, and A P Warin
January 1995, International journal of epidemiology,
J Melia, and E J Cooper, and T Frost, and R Graham-Brown, and J Hunter, and A Marsden, and A Du Vivier, and J White, and S Whitehead, and A P Warin
January 1974, The New England journal of medicine,
J Melia, and E J Cooper, and T Frost, and R Graham-Brown, and J Hunter, and A Marsden, and A Du Vivier, and J White, and S Whitehead, and A P Warin
January 2006, Dermatologic therapy,
Copied contents to your clipboard!